AlgaeCal Inc. is the plaintiff, not the defendant, in its active court cases. In AlgaeCal Inc. v. OceanEssence Nutrition Inc. (No. 1:25-cv-00346, N.D. Illinois, filed January 13, 2025), AlgaeCal sued a competitor over a website that allegedly falsely claimed to independently rank algae-based calcium supplements. Separately, AlgaeCal has pursued domain registrars and website operators, including sites like AlgaeCalFraud.com, over claims of trademark misuse and bad-faith domain registration, a pattern dating back to a 2013 WIPO domain dispute.
No verified public record shows a consumer class action against AlgaeCal for false advertising or bone-density claims. A 2016 study in the Journal of the American College of Nutrition found some long-term users saw increased bone density with no reported adverse effects, but the study was company-funded and wasn’t a randomized, placebo-controlled trial.
AlgaeCal has real lawsuits attached to its name. None of them involve a consumer suing the company over false health claims. Two verified cases exist, and both show AlgaeCal on the offense, not the defense. Search results for “AlgaeCal lawsuit” surface at least one article that gets this backward. It describes AlgaeCal as a defendant facing a consumer class action in Texas. That case doesn’t exist in any court record we could locate.
Here’s what actually happened, and what the science says.
What Is AlgaeCal?
AlgaeCal is a calcium supplement brand built around a plant-based source: calcified marine algae harvested off the coast of South America. The company positions the product as a stronger alternative to standard calcium supplements, aimed at people managing bone density or osteoporosis risk. AlgaeCal Inc. operates as a Canadian corporation with a wholly owned subsidiary, AlgaeCal Distribution Inc., which holds the trademark.
The brand has defended that trademark aggressively since at least 2013, which matters for understanding its legal history below.
Two Real Cases, Explained
Case 1: AlgaeCal v. OceanEssence Nutrition
Filed January 13, 2025, in the U.S. District Court for the Northern District of Illinois, this case (No. 1:25-cv-00346) names AlgaeCal Inc. as plaintiff. AlgaeCal alleges that competitor OceanEssence Nutrition Inc. operated a website that presented itself as an independent, neutral comparison of algae-based calcium supplements, while actually favoring OceanEssence’s own products. The complaint raises false advertising claims and cites the Lanham Act, the federal law governing trademark and unfair competition disputes. Court filings in the case reference precedent from FTC v. Lane Labs-USA, a case involving unsubstantiated health claims, suggesting AlgaeCal’s legal team anticipated arguments about supplement marketing standards.
This is a business dispute. Consumers aren’t parties to it, and no refund or compensation process exists for buyers as a result of this filing.
Case 2: Domain and Trademark Disputes
Separately, AlgaeCal has pursued legal action against domain registrars and website operators tied to sites like AlgaeCalFraud.com and BoneBlast.com. AlgaeCal’s position: these sites impersonate independent review platforms, misuse its trademark, and in some cases conceal ownership through privacy services to avoid accountability. This isn’t new. A 2013 WIPO domain dispute (Case No. D2013-1248) already found in AlgaeCal’s favor over a similarly named domain, establishing a documented pattern the company later cited in follow-up filings.
Again, this is AlgaeCal acting as plaintiff against critics and alleged bad-faith actors, not a case brought by wronged customers.
The Claim You’ll See That Isn’t True
At least one competing article describes a consumer class action against AlgaeCal, heard in the Western District of Texas, alleging the company misled buyers about bone-density benefits and seeking refunds through class certification. We searched federal court records and found no case matching that description. No docket, no case number, no filing date lines up with it.
This matters beyond just getting a fact wrong. If you’re a consumer researching whether to join a legal claim, following instructions built on a case that doesn’t exist wastes your time and could expose you to scams that piggyback on real brand names. Verify any claim about “joining” a lawsuit directly through PACER or a court’s public docket search before giving out personal information.
The 2016 Study: What It Shows and What It Doesn’t
AlgaeCal’s core marketing claim rests on a single long-term study, published in the Journal of the American College of Nutrition in 2016. UCLA Health’s “Ask the Doctors” column referenced it directly in 2021, in response to a reader asking about the product for osteoporosis management.
What the study found:
- Participants using AlgaeCal long-term showed measurable bone density gains.
- No adverse health effects turned up in the tested group.
- The gains accumulated over a multi-year period, not immediately.
What limits how far you can take that finding:
- The study wasn’t randomized or placebo-controlled. The gold standard for proving a supplement causes an effect rather than just correlating with it.
- Participants were already AlgaeCal users, not randomly assigned. People who stick with a supplement for years may differ in diet, activity, or bone health habits from the general population.
- AlgaeCal Inc. funded the research. That doesn’t make the results false, but it’s a conflict worth weighing.
UCLA’s own advice, worth repeating here: talk to a doctor before treating any supplement as a substitute for prescribed osteoporosis treatment. That’s balanced guidance, not a dismissal of the product.
Is AlgaeCal FDA-Approved?
No. Like all dietary supplements, AlgaeCal doesn’t go through FDA approval for effectiveness. The FDA can act after the fact if a company makes illegal disease-treatment claims or fails to report safety issues, but pre-market approval doesn’t apply to supplements the way it does to drugs. No FDA warning letter targeting AlgaeCal specifically was located in public FDA databases as of this update.
What This Means If You’re Considering AlgaeCal
Weigh the real study against the real limits. A company-funded, non-randomized study found bone density gains with no reported safety issues. That’s a genuine data point, not proof that the product works for everyone. If you have kidney disease, a history of high calcium levels, or you’re on osteoporosis medication, loop in your doctor before adding any calcium supplement. The interactions matter more than the marketing.
If you’re trying to determine whether you have any legal claim tied to AlgaeCal, the honest answer is: probably not, based on what’s currently in court records. The company’s active litigation involves other businesses and website operators, not consumers.
If you bought the product based on a specific written claim you believe was false, document it. Save the ad, the receipt, and the date. Report it to the FTC’s consumer complaint system if you believe the marketing crossed a legal line. That’s a real, verifiable path. Following instructions from an article describing a lawsuit that doesn’t appear in any court database is not.
FAQs
Is AlgaeCal facing a real lawsuit in 2026?
Yes, but not from consumers. AlgaeCal is the plaintiff in a false advertising case against a competitor, OceanEssence Nutrition, and has separately pursued domain-related trademark claims. No verified consumer class action exists.
Can I join an AlgaeCal class action lawsuit?
Based on public court records, there’s no class action for consumers to join. Be cautious of any site or ad claiming otherwise, and verify directly through federal court records before submitting personal information anywhere.
Does AlgaeCal really increase bone density?
A 2016 study found some long-term users saw increased bone density with no major reported safety issues. The study wasn’t randomized or placebo-controlled, and AlgaeCal funded it. Treat it as a real but limited data point.
Is AlgaeCal FDA-approved?
No. It’s regulated as a dietary supplement, which doesn’t require FDA pre-market approval for effectiveness.
Who should avoid AlgaeCal?
People with kidney disease, high calcium levels, heart conditions, or those on osteoporosis medications should talk to a doctor before starting it. Combining multiple calcium or bone-health supplements without medical guidance carries real risk.
Why do some articles describe a different AlgaeCal lawsuit?
At least one widely circulated article describes a consumer class action that doesn’t match any locatable federal court record. It may stem from confusion with the real OceanEssence case or the domain disputes, reframed inaccurately. Treat unsourced lawsuit claims with skepticism and verify against PACER directly.
Sources
- CourtListener/PACER, AlgaeCal Inc. v. OceanEssence Nutrition Inc., 1:25-cv-00346, filed January 13, 2025
- Justia Dockets, AlgaeCal Inc. v. OceanEssence Nutrition Inc.
- UCLA Health, Calcium supplement AlgaeCal can increase bone density, May 10, 2021
- WIPO Arbitration and Mediation Center, Case No. D2013-1248
Musarat Bano is a content writer for JudicialOcean.com who covers lawsuits, legal news, and general legal topics. Her work focuses on research-based, informational content developed from publicly available sources and is intended to support public awareness. She does not provide legal advice or professional legal services.
